Back
Heron Therapeutics Vs. Aldeyra Therapeutics Industry Stock Comparison
Sell
47
HRTX
Heron Therapeutics
Last Price:
3.22
Seasonality Move:
3.23%
Buy
62
ALDX
Aldeyra Therapeutics
Last Price:
4.09
Seasonality Move:
25%
Sell
47
Heron Therapeutics (HRTX)
is a Sell
Is Heron Therapeutics a Buy, Sell or Hold?
- The current Heron Therapeutics [HRTX] share price is $3.00. The Score for HRTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- HRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Aldeyra Therapeutics (ALDX)
is a Buy
Is Aldeyra Therapeutics a Buy, Sell or Hold?
- The current Aldeyra Therapeutics [ALDX] share price is $4.17. The Score for ALDX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- ALDX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HRTX Stock Price Chart
What is Heron Therapeutics's stock price today?
-
The Heron Therapeutics share price today is $3.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALDX Stock Price Chart
What is Aldeyra Therapeutics's stock price today?
-
The Aldeyra Therapeutics share price today is $4.17
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALDX is experiencing selling pressure, which indicates risk of future bearish movement.
HRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 59.62 | Buy |
| Chaikin Money Flow: | 2143347 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.53 - 2.93) | Buy |
| Bollinger Bands (100): | (2.17 - 2.89) | Buy |
ALDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 56.38 | Buy |
| Chaikin Money Flow: | -272076 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.87 - 4.19) | Buy |
| Bollinger Bands (100): | (3.09 - 4.03) | Buy |
HRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.88 | Buy |
| 20-day SMA: | 2.69 | Buy |
| 50-day SMA: | 2.75 | Buy |
| 200-day SMA: | 1.87 | Buy |
| 8-day EMA: | 2.84 | Buy |
| 20-day EMA: | 2.76 | Buy |
| 50-day EMA: | 2.69 | Buy |
| 200-day EMA: | 2.25 | Buy |
ALDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.01 | Buy |
| 20-day SMA: | 4.01 | Buy |
| 50-day SMA: | 3.74 | Buy |
| 200-day SMA: | 4.19 | Sell |
| 8-day EMA: | 4.03 | Buy |
| 20-day EMA: | 4 | Buy |
| 50-day EMA: | 3.84 | Buy |
| 200-day EMA: | 4.37 | Sell |
Heron Therapeutics Earnings Growth & HRTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.73 per share, and an increase next year of $0.13 per share.
Aldeyra Therapeutics Earnings Growth & ALDX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.05 per share.
Heron Therapeutics Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aldeyra Therapeutics Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||